Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pressao is a medical technology company developing a next-generation wearable platform for continuous, non-invasive blood pressure monitoring. Originating from research at the MIT Media Lab, the company utilizes proprietary optical sensors and advanced machine learning algorithms to provide cuffless blood pressure readings in real-time. This technology is designed to overcome the limitations of traditional episodic cuff measurements by capturing comprehensive data throughout the day and night, including nocturnal blood pressure fluctuations. By providing a more detailed view of cardiovascular health, Pressao aims to improve the diagnosis and management of hypertension and other related conditions. The company's mission is to integrate seamless physiological monitoring into daily life to reduce the global burden of cardiovascular disease.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pressao.